The programme “24 Horas”, broadcasted by Radio Nacional de España, has interviewed IRB Barcelona researcher Modesto Orozco, co-organiser of the Barcelona Biomed Conference.
From November 13 to 15, this meeting gathered more than twenty experts in the field, with the aim to share advances made in 3D genomics.
Link to Radio Nacional de España (interview starts at 19:40)
Modesto Orozco’s lab has published a paper in Chemical Communications about a therapeutic tool to prevent treatment resistance in breast cancer.
The tool has been tested in tumour cells in vitro and will now need to be tested in animal models before moving on to the development of a valid treatment for patients.
The European Molecular Biology Lab (EMBL) in Barcelona and IRB Barcelona bring together leading scientists in the conference “Morphogenetic Engineering”, an event supported by the BBVA Foundation.
The merge of various disciplines of developmental biology is key to enhancing our knowledge of tissue development and repair, processes that find their most direct applications in regenerative medicine.
“One day we will be able to re-build damaged organs and keep the whole body fit and healthy. But right now we must strengthen our knowledge of how tissues are built and how they are maintained,” say James Sharpe, Head of EMBL Barcelona, and Marco Milán, coordinator of the Cell and Developmental Biology programme.
Fifteen media outlets, including El Periódico de Catalunya, ABC and La Vanguardia, have published an article on the BioMed conference on morphogenetic engineering, which was held from November 27 to 29. The gathering brought together specialists from multiple fields related to development biology with the aim to advance understanding of the generation and repair of organs and tissues.
Media selection:
